Squarepoint Ops »

Engene Therapeutics shares owned by Squarepoint Ops

Quarter-by-quarter ownership of Engene Therapeutics (ENGN) shares owned by Squarepoint Ops from 13F filings

Historical chart of Squarepoint Ops investment in Engene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Engene Therapeutics held by Squarepoint Ops consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Engene Therapeutics by Squarepoint Ops

Quarter filed Position value Share count Share price at filing
2026-06-30 $373k 215k 1.73

More positions owned by Squarepoint Ops

Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Advanced Micro Devices (AMD)
Ishares Tr Russell 2000 Etf (IWM)
Micron Technology (MU)
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Apple (AAPL)
Applied Materials (AMAT)
Tesla Motors (TSLA)
Intel Corporation (INTC)
Ishares Tr 20 Yr Tr Bd Etf (TLT)

View all positions for Squarepoint Ops

Top funds holding Engene Therapeutics

BML Capital Management
Siren
Perceptive Advisors
Ameriprise Financial
Nextech Invest
ADAR1 Capital Management
Vestal Point Capital
Acorn Capital Advisors
Peapod Lane Capital
Balyasny Asset Management
Millennium Management
Renaissance Technologies
Citadel Advisors
Affinity Asset Advisors
UBS Group

View all funds holding Engene Therapeutics